We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure

News   Apr 07, 2020 | Original story from Beth Israel Deaconess Medical Center

 
Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure
 
 
Advertisement
 

RELATED ARTICLES

Single-cell Map of the Heart Reveals Wide Cellular Diversity

News

Researchers have generated the most comprehensive high-resolution cellular map to date of the human heart. By studying nearly 300,000 individual heart cells from seven healthy hearts, the team identified nine major cell types and over 20 subtypes in the organ.

READ MORE

Tracking Food Contamination and Beyond With Genetically Barcoded Microbes

News

In a novel solution that can help determine the origin of agricultural products and other goods, scientists have developed a DNA-barcoded microbial system that can be used to label objects in an inexpensive, scalable and reliable manner.

READ MORE

A Quicker Way To Make Antibody–Drug Conjugates

News

A team has engineered a new, faster way to make antibody–drug conjugates that precisely target malignant cells, while leaving healthy tissue undamaged, that could lead the way to better treatments for numerous types of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE